Dexamethasone for Ureteral STent Symptoms (DUSTS)
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The Methodist Hospital Research Institute
- Study ID
- NCT06930690
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Ureteral Stent-Related Symptom
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Dexamethasone Sodium Phosphate Injection 20 mg — DRUGdexamethasone 20 mg diluted in 50 mL of normal saline administered by intravenous drip after induction of anesthesia
- Dexamethasone Sodium Phosphate Injection 4mg — DRUGdexamethasone 4 mg diluted in 50 mL of normal saline administered by intravenous drip after induction of anesthesia
Study Details
The purpose of this study to learn if high-dose dexamethasone, a type of long-acting steroid, works to decrease urinary symptoms and pain after ureteroscopy and stent placement for kidney stones. The main question it aims to answer is: 1\) Does high-dose steroid change the quality of life score on day 2 after surgery Researchers will compare high-dose of dexamethasone (20 mg) to a standard dose of dexamethasone (4 mg) to see if a higher dose of the drug will help with urinary symptoms and pain Participants will: 1. randomly receive 20 mg or 4 mg of dexamethasone (20 mg) at the time of surgery 2. fill out a questionnaire day 1 and day 2 after surgery 3. fill out a medication diary for one week after surgery 4. visit the clinic on day 2 after surgery for checkup 5. visit the clinic on day 4-7 after surgery for check up
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment ArmDexamethasone 20 mg
- Active Comparator: Control ArmDexamethasone 4 mg
Primary Outcome Measure
Global Quality of Life Score of Ureteral Stent Symptom Questionnaire (USSQ) [ Time Frame: Day 2 after surgery ]
Central Contacts
- Farida Tufail713-269-0186
- Johnny Su, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Houston Methodist Hospital | Houston | Texas | 77005 | Monica Morgan, MD (PRINCIPAL_INVESTIGATOR) Rose Khavari, MD (SUB_INVESTIGATOR) Kathleen Kobashi, MD (SUB_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Impact of Ureteral Stent and Sheaths Size on Post-Operative PainEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Stent Related Symptoms Defined by Ureteral Stent Symptom Questionnaire in Patients With Image-Informed Ureteral Stent LengthsNot Yet Recruiting · Weill Medical College of Cornell University · New York, New York